Page 11 - Christopher Anzalone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopher anzalone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopher Anzalone Today - Breaking & Trending Today

Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2021 Earnings Call Transcript

Operator
Ladies and gentlemen welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today s recorded presentation all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions.
I will now hand the conference call over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead Vince.
Vincent Anzalone
Vice President of Investor Relations
Thank you, Jessi. Good afternoon everyone. Thank you for joining us today to discuss Arrowhead s results for it s Fiscal 2021 Second Quarter ended March 31, 2021. With us today from management are President and CEO, Dr. Christopher Anzalone, who will provide an overview of the quarter; Dr. Javier San Martin, our Chief Medical Officer, who will provide an update on our pipeline; and Ken Myszkowski, our Chief Financial Officer, who will give a review of the financials. In addition, James Hassard, our Chief Commercial Officer, and ....

United States , Ken Myszkowski , James Hassard , Vincent Anzalone , James Hamilton , Christopher Anzalone , Society International Research Congress , Arrowhead Pharmaceuticals Conference Call , Securities Exchange , Arrowhead Pharmaceuticals Inc , Arrowhead Pharmaceuticals , Arrowhead Pharmaceuticals Conference , Vice President , Investor Relations , Javier San Martin , Chief Medical Officer , Chief Financial Officer , Chief Commercial Officer , Senior Vice President , Translational Medicine , Securities Act , Securities Exchange Act , Chief Executive , Single Ascending Dose , Cystic Fibrosis , International Research Congress ,

Arrowhead Pharmaceuticals, Inc (ARWR) Q1 2021 Earnings Call Transcript

Operator
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals conference call. [Operator Instructions] I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, sir.
Vincent Anzalone
Vice President, Head of Investor Relations
Thanks, Aldan. Good afternoon, everyone. Thank you for joining us today to discuss Arrowhead s results for its fiscal 2021 first quarter ended December 31, 2020. With us today from management are President and CEO, Dr. Christopher Anzalone; who will provide an overview of the quarter; Dr. James Hamilton, our Senior Vice President of Discovery and Translational Medicine, who has graciously agreed to sub in for Dr. Javier San Martin while he is out ill today; and Ken Myszkowski, our Chief Financial Officer, who will give a review of the financials. In addition, James Hassard, our Chief Commercial Officer, will be available during the Q&A portion of today s call. ....

United States , Piper Sandler , Maury Raycroft , Christopher Anzalone , James Hassard , Ken Myszkowski , Alethia Young , Esther Rajavelu , Ted Tenthoff , Patrick Trucchio , Vince Anzalone , Estherp Rajavelu , James Hamilton , Salveen Richter , Chris Anzalone , American Heart Association , Maurice Thomas Raycroft Jefferies , Salveen Jaswal Richter Goldman Sachs Group Analyst , Investment Bank Analyst , Goldman Sachs , Arrowhead Pharmaceuticals Inc , Head Of Clinical Development , Arrowhead Pharmaceuticals , European Society Of Cardiology , Shawn Michael Egan Citigroup Inc , Securities Exchange ,